top of page
Highlights
Press release
PR Newswire
July 26, 2024
RetiSpec Closes $10M USD to Advance Commercialization of its AI-Driven Eye Test for Detection of Alzheimer's Disease
News
Scientific American
April 18, 2024
Eye Tests Could Help Preserve Brain Health
Press release
Investors Observer
April 30, 2024
RetiSpec,Topcon Healthcare, Inc. Announce Collaboration, Investment to Help Bring Eye-Based AI Diagnostic Tool to Market
News
November 05, 2024
DAC-SP
Toronto Memory Program and RetiSpec featured as a case study on the Davos Alzheimer's Collaborative Blueprint
News
September 04, 2024
The C100
C100 Announces 2024 Growth and Fellows Program Cohorts
News
August 14, 2024
BNN Bloomberg
Toronto-based company uses AI to detect Alzheimer’s through eye exams
News
July 29, 2024
CPE News
RetiSpec secures US $10M Series A
News
October 28, 2024
Global Newswire
Collaborative effort to conduct a study aimed at improving the diagnosis of Alzheimer’s and related dementias for everyone
News
August 28, 2024
VSP Vision
Future of Senses
News
July 29, 2024
Private Capital Journal
RetiSpec secures US $10M Series A
News
July 29, 2024
Vision Monday
RetiSpec Closes $10 Million to Advance Commercialization of its AI-Driven Eye Test for Detection of Alzheimer's Disease
News
September 05, 2024
The Logic
Toronto’s RetiSpec pushes frontier of Alzheimer’s detection with retinal scan technology
News
August 17, 2024
StartUp Health
RetiSpec Closes $10M for AI-Driven Early Alzheimer's Eye Test
News
July 29, 2024
FINSMES
RetiSpec Closes $10M USD in Series A Funding
News
July 29, 2024
Medical Device Network
RetiSpec secures $10m to accelerate eye test commercialisation
bottom of page